Search

Author/Creator Van Laethem, J

1. O-003Gemcitabine with nab-paclitaxel in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC): A quality of life randomized cross-over study (QOLINPAC). (20th June 2018)

Authors:
Chiritescu, G; Dumon, K; Verslype, C; Prenen, H; Houbiers, G; Peeters, M; Janssens, J; Van Daele, D; Laurent, S; Arts, J; Hendrickx, K; Borbath, I; Ferrante, M; Bastin, F; Goeminne, J; Van Laethem, J; Vanderstraeten, E; Decaestecker, J; Van Vaerenbergh, W; Delhougne, B
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. O-015A two arm phase II study of FOLFIRI in combination with standard or escalating dose of cetuximab as first line treatment for metastatic colorectal cancer: Everest 2 final results. (20th June 2018)

Authors:
Chiritescu, G; Dumon, K; Mercadé, T Macarulla; Lang, I; Vivas, C Santos; Papai, Z; Janssens, J; Hendrickx, K; Pracht, M; Van den Eynde, M; Taïeb, J; Moons, V; Geboes, K; Van Laethem, J; Greil, R; Cervantes, A; Vergauwe, P; Ferrante, M; Vanderstraeten, E; Fridrik, M
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. O-021Safety and antitumor activity of pembrolizumab in patients with advanced microsatellite instability–high (MSI-H) colorectal cancer: KEYNOTE-164. (20th June 2018)

Authors:
Le, D; Kavan, P; Kim, T; Burge, M; Van Cutsem, E; Hara, H; Boland, P; Van Laethem, J; Geva, R; Taniguchi, H; Crocenzi, T; Sharma, M; Atreya, C; Diaz, L; Liang, L; Marinello, P; Dai, T; O'Neill, B
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search